IDiyas

For the Inventor, By the Inventor

Newton, MA, United States of America

Kyungae Lee

USPTO Granted Patents = 18 

 

Average Co-Inventor Count = 6.0

ph-index = 7

Forward Citations = 223(Granted Patents)


Location History:

  • Guilford, CT (US) (2003 - 2011)
  • Newton, MA (US) (2007 - 2017)

Company Filing History:

goldMedal9 out of 305 
 
Neurogen Corporation
 patents
silverMedal6 out of 2,961 
 
Harvard College
 patents
bronzeMedal3 out of 29 
 
Novartis International Pharmaceutical, Ltd.
 patents
4. 3 out of 1,370 
 
The Brigham and Women's Hospital, Inc.
 patents
5. 2 out of 1,551 
 
University of Massachusetts
 patents
6. 1 out of 4,455 
 
Pfizer Corporation
 patents
where one patent can have more than one assignee

Years Active: 2003-2017

where 'Filed Patents' based on already Granted Patents

18 patents (USPTO):
1. 9676763 - Method of treating Ebola (2017-06-13),
2. 9452992 - Small molecule inhibitors of ebola and lassa fever viruses (2016-09-27),
3. 9340505 - Type III secretion inhibitors, analogs and uses thereof (2016-05-17),
4. 9193705 - Small molecule inhibitors of ebola and lassa fever viruses and methods of use (2015-11-24),
5. 8716283 - Type III secretion inhibitors, analogs and uses thereof (2014-05-06),
6. 8598342 - Methods and compounds for antimicrobial intervention (2013-12-03),
7. 8338591 - 3-aryl-5,6-disubstituted pyridazines (2012-12-25),
8. 7915288 - 1-aryl-4-substituted isoquinolines (2011-03-29),
9. 7863454 - 3-substituted-6-aryl pyridines (2011-01-04),
10. 7642267 - Benzimidazole and pyridylimidazole derivatives (2010-01-05),
11. 7342115 - 3-substituted-6-aryl pyridines (2008-03-11),
12. 7300945 - Benzimidazole and pyridylimidazole derivatives (2007-11-27),
13. 7253168 - Substituted 1-benzyl-4-substituted piperazine analogues (2007-08-07),
14. 6949562 - Heterocyclic compounds as ligands of the GABAA receptor (2005-09-27),
15. 6916830 - Substituted tetrahydroisoquinolines as C5a receptor modulators (2005-07-12),

Title: Innovations by Kyungae Lee in Viral Treatment

Introduction

Kyungae Lee, an accomplished inventor based in Newton, MA, has made significant contributions to the field of virology through his innovative patents. With a total of 18 patents to his name, Lee focuses on developing treatments for infections caused by enveloped viruses, highlighting his dedication to addressing critical health issues.

Latest Patents

Among his latest inventions, Lee developed a method for treating Ebola, which encompasses compositions and methodologies aimed at combating infections caused by viruses such as Ebola and Lassa fever. Additionally, he created small molecule inhibitors specifically targeting these enveloped viruses, further showcasing his commitment to advancing medical science in the face of viral threats.

Career Highlights

Kyungae Lee has built a reputable career through his work at esteemed institutions such as Neurogen Corporation and Harvard College. His involvement in these organizations has not only enhanced his expertise but also facilitated groundbreaking research.

Collaborations

Throughout his career, Lee has collaborated with notable colleagues, including George D Maynard and Jun Yuan. These partnerships have enabled the sharing of knowledge and ideas, fostering innovation in the realm of viral treatment.

Conclusion

Kyungae Lee's work is a testament to the importance of innovation in addressing global health challenges. His contributions as an inventor, particularly in developing treatments for severe viral infections, underscore the vital role of research and collaboration in the advancement of medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…